Emb-Fatol 400

EMB-Fatol 400: Anti-tuberculosis drug from Germany

EMB-Fatol 400 is one of the anti-tuberculosis drugs produced in Germany. This drug belongs to the pharmacological group of anti-tuberculosis drugs belonging to various chemical groups.

The manufacturer of EMB-Fatol 400 is Fatol Artsneimittel GmbH, based in Germany. The international name of this drug is Ethambutol. There are also several synonyms by which the drug may be known: Apbutol, Combutol, Li-butol, Libutol, Miambutol, Mycobutol, Temibutol, Ebutol, Enbutol, Ethambusin, Ethambutol, Ethambutol-Acri.

The dosage form of EMB-Fatol 400 is presented in the form of tablets containing 400 mg of the active substance - Ethambutol.

The drug is used to treat tuberculosis. However, there are also contraindications to its use, including hypersensitivity to the drug, gout, optic neuritis, cataracts, inflammatory eye diseases, diabetic retinopathy, renal dysfunction and pregnancy. In addition, when treating with EMB-Fatol 400, breastfeeding must be stopped.

The drug may cause side effects such as dyspeptic symptoms (nausea, vomiting, abdominal pain), dizziness, spatial disorientation, hallucinations, peripheral neuritis, optic neuritis, exacerbation of gout, leukopenia, hyperuricemia and allergic reactions.

The interaction of EMB-Fatol 400 with other drugs may manifest itself in increased effects of anti-tuberculosis drugs and neurotoxicity of aminoglycosides, asparaginase, carbamazepine, ciprofloxacin, imipenem, lithium salts, methotrexate and quinine.

Information on overdose and special instructions for the use of EMB-Fatol 400 is not included in the data provided.

Literary sources mentioned in the description of the drug include the 2004 Encyclopedia of Drugs.

EMB-Fatol 400 is an anti-tuberculosis drug developed in Germany, which offers a dosage form in the form of 400 mg tablets with the active ingredient Ethambutol. It is widely used in the treatment of tuberculosis, but its use should only be considered after consultation with a doctor.